Share Price and Basic Stock Data
Last Updated: January 23, 2026, 9:48 pm
| PEG Ratio | 0.38 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Aplab Ltd operates within the instrumentation and process control industry, reporting a current market capitalization of ₹151 Cr and a share price of ₹65.4. The company has shown fluctuating revenue trends, with sales for the trailing twelve months (TTM) standing at ₹72.67 Cr. In the quarterly performance, Aplab recorded sales of ₹10.56 Cr in September 2022, which rose significantly to ₹18.49 Cr by March 2023 before experiencing a dip to ₹9.11 Cr in June 2023. Recent quarterly data indicates a recovery, with sales rising to ₹10.88 Cr in September 2023 and projected to reach ₹15.94 Cr by December 2024. This growth trajectory highlights a potential rebound, although the overall annual sales have shown a slight decline from ₹51.48 Cr in March 2023 to ₹49.05 Cr in March 2024. This inconsistent revenue pattern may raise concerns about market stability and demand for Aplab’s products.
Profitability and Efficiency Metrics
Aplab’s profitability metrics reflect challenges in maintaining operational efficiency. The company’s operating profit margin (OPM) reported a peak of 39.05% in March 2023, but this has since declined to 12.06% in March 2024. The net profit for the TTM stood at ₹1.09 Cr, with a modest net profit margin of 1.50%. The return on equity (ROE) was reported at a low 2.95%, indicating limited returns for shareholders. Efficiency metrics also reveal a cash conversion cycle (CCC) of 219.18 days, which is significantly high compared to typical industry standards, suggesting potential inefficiencies in inventory and collections management. Furthermore, the interest coverage ratio (ICR) at -0.39x signals that Aplab is struggling to meet its interest obligations, which could be a red flag for investors regarding financial health.
Balance Sheet Strength and Financial Ratios
Aplab’s balance sheet reveals a challenging financial landscape, with total borrowings amounting to ₹26.81 Cr against reserves of only ₹3.20 Cr. This indicates a high reliance on debt financing, which could pose risks, especially in a rising interest rate environment. The company reported a price-to-book value ratio of -2.24x, suggesting that the market values Aplab at a significant discount compared to its book value. The current ratio, indicating liquidity, is notably low, implying potential difficulties in meeting short-term obligations. However, total liabilities have decreased from ₹75.51 Cr in March 2023 to ₹71.34 Cr in March 2024, reflecting some improvement in financial management. The negative trends in key ratios, such as return on capital employed (ROCE) at -8.82%, further emphasize the need for Aplab to enhance operational efficiency and profitability.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Aplab Ltd reflects a diverse ownership structure, with promoters holding 43.83% of the equity as of September 2025. This represents a decline from a high of 67.61% in December 2024, suggesting a potential dilution of promoter confidence or strategic divestment. Institutional investors, including domestic institutional investors (DIIs), hold a mere 0.01%, indicating a lack of institutional interest. The public holds a significant 56.16%, with the total number of shareholders increasing to 5,619. This suggests a growing retail investor base, but the low institutional participation could indicate concerns over the company’s financial health and growth prospects. The decline in promoter holding may also affect investor sentiment and confidence in Aplab’s long-term strategy.
Outlook, Risks, and Final Insight
Aplab Ltd faces a mixed outlook characterized by both opportunities and significant risks. On one hand, the recent uptick in sales and potential recovery in operating margins could provide a foundation for future growth. However, the company’s financial challenges, including high debt levels, negative profitability ratios, and operational inefficiencies, pose serious risks. Aplab must address its cash conversion cycle and improve its interest coverage to enhance financial stability. Should the company successfully implement strategic operational improvements and regain investor confidence, it could stabilize and grow. Conversely, continued financial mismanagement and market volatility may lead to further declines in profitability and market valuation. Aplab’s ability to navigate these challenges will be crucial for its sustainability and growth in the competitive instrumentation sector.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Aplab Ltd | 157 Cr. | 68.2 | 93.0/28.2 | 15.3 | 7.53 | 0.00 % | 8.82 % | 2.95 % | 10.0 |
| Industry Average | 157.00 Cr | 68.20 | 15.30 | 7.53 | 0.00% | 8.82% | 2.95% | 10.00 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 10.56 | 11.54 | 18.49 | 9.11 | 10.88 | 11.93 | 17.61 | 9.93 | 13.86 | 15.94 | 23.93 | 15.45 | 17.35 |
| Expenses | 11.49 | 10.54 | 11.27 | 8.34 | 9.34 | 11.19 | 15.88 | 9.10 | 13.26 | 23.94 | 25.33 | 13.71 | 14.29 |
| Operating Profit | -0.93 | 1.00 | 7.22 | 0.77 | 1.54 | 0.74 | 1.73 | 0.83 | 0.60 | -8.00 | -1.40 | 1.74 | 3.06 |
| OPM % | -8.81% | 8.67% | 39.05% | 8.45% | 14.15% | 6.20% | 9.82% | 8.36% | 4.33% | -50.19% | -5.85% | 11.26% | 17.64% |
| Other Income | 0.07 | -0.41 | 0.06 | 0.06 | 0.06 | 0.05 | -0.03 | 0.06 | 1.88 | 0.46 | 2.69 | 0.19 | 0.08 |
| Interest | 0.66 | 0.75 | 0.93 | 0.67 | 1.35 | 0.33 | 1.09 | 0.67 | 0.82 | 0.77 | 0.95 | 0.68 | 0.95 |
| Depreciation | 0.12 | 0.12 | 0.08 | 0.14 | 0.11 | 0.08 | 0.12 | 0.12 | 0.13 | 0.10 | 0.13 | 0.12 | 0.11 |
| Profit before tax | -1.64 | -0.28 | 6.27 | 0.02 | 0.14 | 0.38 | 0.49 | 0.10 | 1.53 | -8.41 | 0.21 | 1.13 | 2.08 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -3,252.38% | 24.78% | 22.60% |
| Net Profit | -1.64 | -0.28 | 6.27 | 0.02 | 0.14 | 0.38 | 0.49 | 0.10 | 1.53 | -8.41 | 7.04 | 0.85 | 1.61 |
| EPS in Rs | -0.82 | -0.14 | 3.14 | 0.01 | 0.06 | 0.17 | 0.22 | 0.05 | 0.69 | -3.35 | 2.80 | 0.34 | 0.64 |
Last Updated: December 28, 2025, 3:31 am
Below is a detailed analysis of the quarterly data for Aplab Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 17.35 Cr.. The value appears strong and on an upward trend. It has increased from 15.45 Cr. (Jun 2025) to 17.35 Cr., marking an increase of 1.90 Cr..
- For Expenses, as of Sep 2025, the value is 14.29 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 13.71 Cr. (Jun 2025) to 14.29 Cr., marking an increase of 0.58 Cr..
- For Operating Profit, as of Sep 2025, the value is 3.06 Cr.. The value appears strong and on an upward trend. It has increased from 1.74 Cr. (Jun 2025) to 3.06 Cr., marking an increase of 1.32 Cr..
- For OPM %, as of Sep 2025, the value is 17.64%. The value appears strong and on an upward trend. It has increased from 11.26% (Jun 2025) to 17.64%, marking an increase of 6.38%.
- For Other Income, as of Sep 2025, the value is 0.08 Cr.. The value appears to be declining and may need further review. It has decreased from 0.19 Cr. (Jun 2025) to 0.08 Cr., marking a decrease of 0.11 Cr..
- For Interest, as of Sep 2025, the value is 0.95 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.68 Cr. (Jun 2025) to 0.95 Cr., marking an increase of 0.27 Cr..
- For Depreciation, as of Sep 2025, the value is 0.11 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.12 Cr. (Jun 2025) to 0.11 Cr., marking a decrease of 0.01 Cr..
- For Profit before tax, as of Sep 2025, the value is 2.08 Cr.. The value appears strong and on an upward trend. It has increased from 1.13 Cr. (Jun 2025) to 2.08 Cr., marking an increase of 0.95 Cr..
- For Tax %, as of Sep 2025, the value is 22.60%. The value appears to be improving (decreasing) as expected. It has decreased from 24.78% (Jun 2025) to 22.60%, marking a decrease of 2.18%.
- For Net Profit, as of Sep 2025, the value is 1.61 Cr.. The value appears strong and on an upward trend. It has increased from 0.85 Cr. (Jun 2025) to 1.61 Cr., marking an increase of 0.76 Cr..
- For EPS in Rs, as of Sep 2025, the value is 0.64. The value appears strong and on an upward trend. It has increased from 0.34 (Jun 2025) to 0.64, marking an increase of 0.30.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:13 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 94.86 | 74.18 | 70.89 | 72.04 | 61.03 | 53.19 | 51.47 | 53.02 | 51.36 | 51.48 | 49.05 | 63.67 | 72.67 |
| Expenses | 82.20 | 76.93 | 76.44 | 74.36 | 65.02 | 55.68 | 47.45 | 47.75 | 44.42 | 45.27 | 44.52 | 71.64 | 77.27 |
| Operating Profit | 12.66 | -2.75 | -5.55 | -2.32 | -3.99 | -2.49 | 4.02 | 5.27 | 6.94 | 6.21 | 4.53 | -7.97 | -4.60 |
| OPM % | 13.35% | -3.71% | -7.83% | -3.22% | -6.54% | -4.68% | 7.81% | 9.94% | 13.51% | 12.06% | 9.24% | -12.52% | -6.33% |
| Other Income | 0.93 | 0.71 | 0.82 | 1.55 | 0.38 | 18.50 | 3.42 | 1.32 | -1.08 | -1.72 | 0.24 | 5.09 | 3.42 |
| Interest | 10.22 | 10.63 | 11.24 | 11.21 | 10.82 | 8.06 | 6.21 | 6.60 | 5.31 | 3.84 | 3.53 | 3.20 | 3.35 |
| Depreciation | 2.78 | 1.76 | 1.62 | 1.56 | 1.44 | 1.29 | 1.02 | 0.38 | 0.38 | 0.45 | 0.44 | 0.49 | 0.46 |
| Profit before tax | 0.59 | -14.43 | -17.59 | -13.54 | -15.87 | 6.66 | 0.21 | -0.39 | 0.17 | 0.20 | 0.80 | -6.57 | -4.99 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 18.77% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -103.96% | |
| Net Profit | 0.59 | -14.43 | -17.59 | -13.54 | -15.87 | 5.41 | 0.21 | -0.39 | 0.17 | 0.20 | 0.80 | 0.26 | 1.09 |
| EPS in Rs | 0.30 | -7.22 | -8.80 | -6.77 | -7.94 | 2.70 | 0.10 | -0.20 | 0.08 | 0.10 | 0.36 | 0.10 | 0.43 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -2545.76% | -21.90% | 23.02% | -17.21% | 134.09% | -96.12% | -285.71% | 143.59% | 17.65% | 300.00% | -67.50% |
| Change in YoY Net Profit Growth (%) | 0.00% | 2523.86% | 44.92% | -40.23% | 151.30% | -230.21% | -189.60% | 429.30% | -125.94% | 282.35% | -367.50% |
Aplab Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -2% |
| 5 Years: | 4% |
| 3 Years: | 7% |
| TTM: | 37% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 16% |
| 3 Years: | -45% |
| TTM: | -42% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 19% |
| 5 Years: | 61% |
| 3 Years: | 73% |
| 1 Year: | 22% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | 3% |
Last Updated: September 5, 2025, 2:21 pm
Balance Sheet
Last Updated: December 4, 2025, 2:23 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 10.00 | 10.00 | 11.09 | 12.57 | 15.71 |
| Reserves | 21.84 | 7.02 | -10.57 | -23.03 | -37.54 | -31.64 | -31.38 | -31.08 | -30.76 | -29.81 | -3.83 | -2.19 | 3.20 |
| Borrowings | 74.85 | 72.78 | 71.71 | 66.30 | 70.28 | 70.20 | 71.36 | 71.71 | 47.62 | 50.24 | 28.84 | 29.93 | 26.81 |
| Other Liabilities | 48.83 | 42.05 | 65.49 | 70.61 | 68.55 | 59.67 | 48.54 | 43.90 | 39.54 | 45.08 | 35.24 | 29.65 | 22.78 |
| Total Liabilities | 150.52 | 126.85 | 131.63 | 118.88 | 106.29 | 103.23 | 93.52 | 89.53 | 66.40 | 75.51 | 71.34 | 69.96 | 68.50 |
| Fixed Assets | 57.68 | 55.04 | 53.33 | 51.61 | 16.78 | 4.26 | 3.70 | 3.47 | 6.54 | 7.37 | 7.03 | 6.72 | 6.69 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.35 | 0.82 | 2.35 | 3.59 | 3.88 | 1.08 | 0.00 | 0.49 | 1.21 | 1.09 |
| Investments | 2.26 | 0.07 | 0.07 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.03 | 0.03 |
| Other Assets | 90.58 | 71.74 | 78.23 | 66.90 | 88.67 | 96.60 | 86.21 | 82.16 | 58.76 | 68.12 | 63.80 | 62.00 | 60.69 |
| Total Assets | 150.52 | 126.85 | 131.63 | 118.88 | 106.29 | 103.23 | 93.52 | 89.53 | 66.40 | 75.51 | 71.34 | 69.96 | 68.50 |
Below is a detailed analysis of the balance sheet data for Aplab Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 15.71 Cr.. The value appears strong and on an upward trend. It has increased from 12.57 Cr. (Mar 2025) to 15.71 Cr., marking an increase of 3.14 Cr..
- For Reserves, as of Sep 2025, the value is 3.20 Cr.. The value appears strong and on an upward trend. It has increased from -2.19 Cr. (Mar 2025) to 3.20 Cr., marking an increase of 5.39 Cr..
- For Borrowings, as of Sep 2025, the value is 26.81 Cr.. The value appears to be improving (decreasing). However, Borrowings exceed Reserves, which may signal higher financial risk. It has decreased from 29.93 Cr. (Mar 2025) to 26.81 Cr., marking a decrease of 3.12 Cr..
- For Other Liabilities, as of Sep 2025, the value is 22.78 Cr.. The value appears to be improving (decreasing). It has decreased from 29.65 Cr. (Mar 2025) to 22.78 Cr., marking a decrease of 6.87 Cr..
- For Total Liabilities, as of Sep 2025, the value is 68.50 Cr.. The value appears to be improving (decreasing). It has decreased from 69.96 Cr. (Mar 2025) to 68.50 Cr., marking a decrease of 1.46 Cr..
- For Fixed Assets, as of Sep 2025, the value is 6.69 Cr.. The value appears to be declining and may need further review. It has decreased from 6.72 Cr. (Mar 2025) to 6.69 Cr., marking a decrease of 0.03 Cr..
- For CWIP, as of Sep 2025, the value is 1.09 Cr.. The value appears to be declining and may need further review. It has decreased from 1.21 Cr. (Mar 2025) to 1.09 Cr., marking a decrease of 0.12 Cr..
- For Investments, as of Sep 2025, the value is 0.03 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.03 Cr..
- For Other Assets, as of Sep 2025, the value is 60.69 Cr.. The value appears to be declining and may need further review. It has decreased from 62.00 Cr. (Mar 2025) to 60.69 Cr., marking a decrease of 1.31 Cr..
- For Total Assets, as of Sep 2025, the value is 68.50 Cr.. The value appears to be declining and may need further review. It has decreased from 69.96 Cr. (Mar 2025) to 68.50 Cr., marking a decrease of 1.46 Cr..
However, the Borrowings (26.81 Cr.) are higher than the Reserves (3.20 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -62.19 | -75.53 | -77.26 | -68.62 | -74.27 | -72.69 | -67.34 | -66.44 | -40.68 | -44.03 | -24.31 | -37.90 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 109.66 | 90.00 | 102.77 | 88.92 | 36.42 | 131.89 | 134.24 | 104.71 | 124.51 | 212.92 | 169.22 | 124.51 |
| Inventory Days | 288.61 | 275.19 | 152.39 | 102.72 | 168.84 | 184.91 | 301.69 | 243.23 | 300.66 | 544.09 | 663.21 | 193.62 |
| Days Payable | 198.46 | 103.01 | 192.21 | 18.98 | 156.27 | 152.70 | 164.50 | 167.18 | 129.08 | 194.05 | 190.71 | 98.96 |
| Cash Conversion Cycle | 199.81 | 262.18 | 62.95 | 172.66 | 48.99 | 164.11 | 271.42 | 180.76 | 296.09 | 562.96 | 641.72 | 219.18 |
| Working Capital Days | -122.51 | -170.15 | -426.01 | -462.58 | -255.08 | -276.61 | -328.98 | -320.05 | -293.58 | -194.91 | 3.13 | -17.26 |
| ROCE % | 11.00% | -4.08% | -8.40% | -4.91% | -11.74% | -8.51% | 7.41% | 13.71% | 18.98% | 21.64% | 14.91% | -8.82% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 16 | Mar 15 | Mar 14 | Mar 13 | Mar 12 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | -35.15 | -28.42 | 1.69 | -28.12 | -3.61 |
| Diluted EPS (Rs.) | -35.15 | -28.42 | 1.69 | -28.12 | -3.61 |
| Cash EPS (Rs.) | -31.37 | -24.41 | 7.54 | -23.24 | 1.60 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | -8.81 | 26.34 | 55.53 | 47.41 | 43.80 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | -8.77 | 26.39 | 55.59 | 47.47 | 44.03 |
| Revenue From Operations / Share (Rs.) | 142.20 | 149.14 | 191.06 | 142.68 | 194.29 |
| PBDIT / Share (Rs.) | -8.88 | -3.06 | 28.21 | -5.09 | 19.70 |
| PBIT / Share (Rs.) | -12.66 | -7.08 | 22.36 | -9.97 | 14.50 |
| PBT / Share (Rs.) | -35.14 | -28.33 | 1.91 | -28.17 | -3.48 |
| Net Profit / Share (Rs.) | -35.15 | -28.42 | 1.69 | -28.12 | -3.59 |
| NP After MI And SOA / Share (Rs.) | -35.15 | -28.42 | 1.69 | -28.12 | -3.59 |
| PBDIT Margin (%) | -6.24 | -2.05 | 14.76 | -3.56 | 10.13 |
| PBIT Margin (%) | -8.90 | -4.74 | 11.70 | -6.99 | 7.46 |
| PBT Margin (%) | -24.70 | -18.99 | 1.00 | -19.74 | -1.79 |
| Net Profit Margin (%) | -24.71 | -19.05 | 0.88 | -19.70 | -1.85 |
| NP After MI And SOA Margin (%) | -24.71 | -19.05 | 0.88 | -19.70 | -1.85 |
| Return on Networth / Equity (%) | 0.00 | -112.18 | 3.09 | -60.09 | -8.24 |
| Return on Capital Employeed (%) | -87.40 | -8.90 | 22.07 | -10.19 | 21.15 |
| Return On Assets (%) | -13.14 | -11.07 | 0.56 | -10.59 | -1.53 |
| Long Term Debt / Equity (X) | 0.00 | 0.58 | 0.46 | 0.57 | 0.43 |
| Total Debt / Equity (X) | -16.98 | 5.50 | 2.67 | 2.90 | 2.75 |
| Asset Turnover Ratio (%) | 0.54 | 0.53 | 0.67 | 0.57 | 0.81 |
| Current Ratio (X) | 0.39 | 0.57 | 0.67 | 0.74 | 0.96 |
| Quick Ratio (X) | 0.24 | 0.20 | 0.31 | 0.22 | 0.34 |
| Inventory Turnover Ratio (X) | 1.65 | 1.25 | 1.24 | 0.68 | 1.19 |
| Interest Coverage Ratio (X) | -0.39 | -0.14 | 1.38 | -0.27 | 1.10 |
| Interest Coverage Ratio (Post Tax) (X) | -0.56 | -0.33 | 1.08 | -0.56 | 0.80 |
| Enterprise Value (Cr.) | 88.89 | 87.10 | 88.96 | 75.60 | 70.92 |
| EV / Net Operating Revenue (X) | 1.25 | 1.17 | 0.93 | 1.06 | 0.73 |
| EV / EBITDA (X) | -20.01 | -56.88 | 6.31 | -29.70 | 7.20 |
| MarketCap / Net Operating Revenue (X) | 0.15 | 0.19 | 0.16 | 0.15 | 0.13 |
| Price / BV (X) | -2.24 | 1.16 | 0.57 | 0.45 | 0.61 |
| Price / Net Operating Revenue (X) | 0.15 | 0.19 | 0.16 | 0.15 | 0.13 |
| EarningsYield | -1.60 | -0.96 | 0.05 | -1.31 | -0.13 |
After reviewing the key financial ratios for Aplab Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 16, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 15) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 16, the value is -35.15. This value is below the healthy minimum of 5. It has decreased from -28.42 (Mar 15) to -35.15, marking a decrease of 6.73.
- For Diluted EPS (Rs.), as of Mar 16, the value is -35.15. This value is below the healthy minimum of 5. It has decreased from -28.42 (Mar 15) to -35.15, marking a decrease of 6.73.
- For Cash EPS (Rs.), as of Mar 16, the value is -31.37. This value is below the healthy minimum of 3. It has decreased from -24.41 (Mar 15) to -31.37, marking a decrease of 6.96.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 16, the value is -8.81. It has decreased from 26.34 (Mar 15) to -8.81, marking a decrease of 35.15.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 16, the value is -8.77. It has decreased from 26.39 (Mar 15) to -8.77, marking a decrease of 35.16.
- For Revenue From Operations / Share (Rs.), as of Mar 16, the value is 142.20. It has decreased from 149.14 (Mar 15) to 142.20, marking a decrease of 6.94.
- For PBDIT / Share (Rs.), as of Mar 16, the value is -8.88. This value is below the healthy minimum of 2. It has decreased from -3.06 (Mar 15) to -8.88, marking a decrease of 5.82.
- For PBIT / Share (Rs.), as of Mar 16, the value is -12.66. This value is below the healthy minimum of 0. It has decreased from -7.08 (Mar 15) to -12.66, marking a decrease of 5.58.
- For PBT / Share (Rs.), as of Mar 16, the value is -35.14. This value is below the healthy minimum of 0. It has decreased from -28.33 (Mar 15) to -35.14, marking a decrease of 6.81.
- For Net Profit / Share (Rs.), as of Mar 16, the value is -35.15. This value is below the healthy minimum of 2. It has decreased from -28.42 (Mar 15) to -35.15, marking a decrease of 6.73.
- For NP After MI And SOA / Share (Rs.), as of Mar 16, the value is -35.15. This value is below the healthy minimum of 2. It has decreased from -28.42 (Mar 15) to -35.15, marking a decrease of 6.73.
- For PBDIT Margin (%), as of Mar 16, the value is -6.24. This value is below the healthy minimum of 10. It has decreased from -2.05 (Mar 15) to -6.24, marking a decrease of 4.19.
- For PBIT Margin (%), as of Mar 16, the value is -8.90. This value is below the healthy minimum of 10. It has decreased from -4.74 (Mar 15) to -8.90, marking a decrease of 4.16.
- For PBT Margin (%), as of Mar 16, the value is -24.70. This value is below the healthy minimum of 10. It has decreased from -18.99 (Mar 15) to -24.70, marking a decrease of 5.71.
- For Net Profit Margin (%), as of Mar 16, the value is -24.71. This value is below the healthy minimum of 5. It has decreased from -19.05 (Mar 15) to -24.71, marking a decrease of 5.66.
- For NP After MI And SOA Margin (%), as of Mar 16, the value is -24.71. This value is below the healthy minimum of 8. It has decreased from -19.05 (Mar 15) to -24.71, marking a decrease of 5.66.
- For Return on Networth / Equity (%), as of Mar 16, the value is 0.00. This value is below the healthy minimum of 15. It has increased from -112.18 (Mar 15) to 0.00, marking an increase of 112.18.
- For Return on Capital Employeed (%), as of Mar 16, the value is -87.40. This value is below the healthy minimum of 10. It has decreased from -8.90 (Mar 15) to -87.40, marking a decrease of 78.50.
- For Return On Assets (%), as of Mar 16, the value is -13.14. This value is below the healthy minimum of 5. It has decreased from -11.07 (Mar 15) to -13.14, marking a decrease of 2.07.
- For Long Term Debt / Equity (X), as of Mar 16, the value is 0.00. This value is below the healthy minimum of 0.2. It has decreased from 0.58 (Mar 15) to 0.00, marking a decrease of 0.58.
- For Total Debt / Equity (X), as of Mar 16, the value is -16.98. This value is within the healthy range. It has decreased from 5.50 (Mar 15) to -16.98, marking a decrease of 22.48.
- For Asset Turnover Ratio (%), as of Mar 16, the value is 0.54. It has increased from 0.53 (Mar 15) to 0.54, marking an increase of 0.01.
- For Current Ratio (X), as of Mar 16, the value is 0.39. This value is below the healthy minimum of 1.5. It has decreased from 0.57 (Mar 15) to 0.39, marking a decrease of 0.18.
- For Quick Ratio (X), as of Mar 16, the value is 0.24. This value is below the healthy minimum of 1. It has increased from 0.20 (Mar 15) to 0.24, marking an increase of 0.04.
- For Inventory Turnover Ratio (X), as of Mar 16, the value is 1.65. This value is below the healthy minimum of 4. It has increased from 1.25 (Mar 15) to 1.65, marking an increase of 0.40.
- For Interest Coverage Ratio (X), as of Mar 16, the value is -0.39. This value is below the healthy minimum of 3. It has decreased from -0.14 (Mar 15) to -0.39, marking a decrease of 0.25.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 16, the value is -0.56. This value is below the healthy minimum of 3. It has decreased from -0.33 (Mar 15) to -0.56, marking a decrease of 0.23.
- For Enterprise Value (Cr.), as of Mar 16, the value is 88.89. It has increased from 87.10 (Mar 15) to 88.89, marking an increase of 1.79.
- For EV / Net Operating Revenue (X), as of Mar 16, the value is 1.25. This value is within the healthy range. It has increased from 1.17 (Mar 15) to 1.25, marking an increase of 0.08.
- For EV / EBITDA (X), as of Mar 16, the value is -20.01. This value is below the healthy minimum of 5. It has increased from -56.88 (Mar 15) to -20.01, marking an increase of 36.87.
- For MarketCap / Net Operating Revenue (X), as of Mar 16, the value is 0.15. This value is below the healthy minimum of 1. It has decreased from 0.19 (Mar 15) to 0.15, marking a decrease of 0.04.
- For Price / BV (X), as of Mar 16, the value is -2.24. This value is below the healthy minimum of 1. It has decreased from 1.16 (Mar 15) to -2.24, marking a decrease of 3.40.
- For Price / Net Operating Revenue (X), as of Mar 16, the value is 0.15. This value is below the healthy minimum of 1. It has decreased from 0.19 (Mar 15) to 0.15, marking a decrease of 0.04.
- For EarningsYield, as of Mar 16, the value is -1.60. This value is below the healthy minimum of 5. It has decreased from -0.96 (Mar 15) to -1.60, marking a decrease of 0.64.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Aplab Ltd:
- Net Profit Margin: -24.71%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: -87.4% (Industry Average ROCE: 8.82%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 0% (Industry Average ROE: 2.95%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): -0.56
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.24
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 15.3 (Industry average Stock P/E: 15.3)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: -16.98
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: -24.71%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Instrumentation & Process Control | Plot No. 12, TTC Industrial Area Thane Belapur Road, Digha, New Mumbai Maharashtra 400708 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mrs. Amrita P Deodhar | Chairperson & Whole Time Director |
| Mr. Sanjay N Mehta | Managing Director |
| Mr. S K Hajela | Non Exe.Non Ind.Director |
| Mrs. Uma Balakrishnan | Independent Director |
| Mr. Haresh G Desai | Independent Director |
FAQ
What is the intrinsic value of Aplab Ltd?
Aplab Ltd's intrinsic value (as of 25 January 2026) is ₹3.88 which is 94.31% lower the current market price of ₹68.20, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹157 Cr. market cap, FY2025-2026 high/low of ₹93.0/28.2, reserves of ₹3.20 Cr, and liabilities of ₹68.50 Cr.
What is the Market Cap of Aplab Ltd?
The Market Cap of Aplab Ltd is 157 Cr..
What is the current Stock Price of Aplab Ltd as on 25 January 2026?
The current stock price of Aplab Ltd as on 25 January 2026 is ₹68.2.
What is the High / Low of Aplab Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Aplab Ltd stocks is ₹93.0/28.2.
What is the Stock P/E of Aplab Ltd?
The Stock P/E of Aplab Ltd is 15.3.
What is the Book Value of Aplab Ltd?
The Book Value of Aplab Ltd is 7.53.
What is the Dividend Yield of Aplab Ltd?
The Dividend Yield of Aplab Ltd is 0.00 %.
What is the ROCE of Aplab Ltd?
The ROCE of Aplab Ltd is 8.82 %.
What is the ROE of Aplab Ltd?
The ROE of Aplab Ltd is 2.95 %.
What is the Face Value of Aplab Ltd?
The Face Value of Aplab Ltd is 10.0.